Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorders
ICD-10 F13.18 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorders.
F13.18 refers to a condition characterized by the abuse of sedative, hypnotic, or anxiolytic substances, leading to various induced disorders. This includes a range of psychological and physiological symptoms resulting from the misuse of these substances, such as anxiety, mood disturbances, and cognitive impairments. Patients may present with withdrawal symptoms when not using the substance, which can include tremors, insomnia, and increased anxiety. The abuse of these substances can lead to significant impairment in social, occupational, or other important areas of functioning. Treatment often involves a combination of behavioral therapies, counseling, and, in some cases, medication to manage withdrawal symptoms and reduce cravings. It is crucial for healthcare providers to conduct thorough assessments to differentiate between substance use disorders and other mental health conditions, ensuring appropriate treatment plans are developed.
Detailed patient history, including substance use patterns and mental health evaluations.
Patients presenting with anxiety disorders exacerbated by substance use.
Consideration of dual diagnosis and the impact of substance use on mental health treatment.
Comprehensive assessments including DSM-5 criteria for substance use disorders.
Patients undergoing detoxification and rehabilitation for sedative abuse.
Focus on treatment adherence and monitoring for relapse.
Used in conjunction with substance abuse treatment.
Document counseling sessions and patient progress.
May be relevant in addiction medicine settings.
F13.18 is used when there is evidence of abuse and associated disorders, while F13.10 is for cases of dependence without abuse.
